LLGL1
Basic information
Region (hg38): 17:18225635-18244875
Previous symbols: [ "DLG4", "LLGL", "HUGL", "HUGL-1" ]
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LLGL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 61 | 67 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 61 | 5 | 9 |
Variants in LLGL1
This is a list of pathogenic ClinVar variants found in the LLGL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-18225727-C-T | Likely benign (Nov 09, 2020) | |||
17-18225762-A-G | not specified | Uncertain significance (Apr 08, 2023) | ||
17-18229963-A-G | Benign (Oct 24, 2018) | |||
17-18229974-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
17-18229990-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
17-18232497-A-G | not specified | Uncertain significance (Mar 28, 2024) | ||
17-18232533-G-A | not specified | Uncertain significance (May 20, 2024) | ||
17-18232571-G-A | not specified | Uncertain significance (Jan 03, 2022) | ||
17-18232723-G-T | not specified | Uncertain significance (Sep 29, 2022) | ||
17-18232785-C-T | Benign (May 30, 2018) | |||
17-18233783-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
17-18233808-G-A | Benign (Jun 18, 2018) | |||
17-18233827-A-A | Benign (Oct 10, 2018) | |||
17-18233890-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
17-18233920-G-T | not specified | Uncertain significance (Jul 19, 2022) | ||
17-18233926-G-C | not specified | Uncertain significance (Apr 08, 2022) | ||
17-18233933-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
17-18234014-G-A | Benign (May 30, 2018) | |||
17-18234023-G-A | not specified | Uncertain significance (May 25, 2022) | ||
17-18234078-G-A | not specified | Likely benign (Apr 19, 2024) | ||
17-18234147-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
17-18234156-A-G | not specified | Likely benign (Jan 08, 2024) | ||
17-18234310-C-G | not specified | Uncertain significance (Nov 18, 2023) | ||
17-18234376-C-G | not specified | Uncertain significance (Sep 22, 2022) | ||
17-18234687-C-T | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LLGL1 | protein_coding | protein_coding | ENST00000316843 | 22 | 19289 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000247 | 1.00 | 125717 | 0 | 30 | 125747 | 0.000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.45 | 575 | 682 | 0.843 | 0.0000464 | 6823 |
Missense in Polyphen | 188 | 267.13 | 0.70377 | 2671 | ||
Synonymous | -2.16 | 341 | 294 | 1.16 | 0.0000212 | 2261 |
Loss of Function | 4.16 | 17 | 48.1 | 0.353 | 0.00000247 | 508 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000342 | 0.000334 |
Ashkenazi Jewish | 0.000399 | 0.000397 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000147 | 0.000139 |
European (Non-Finnish) | 0.000107 | 0.000105 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000987 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cortical cytoskeleton protein found in a complex involved in maintaining cell polarity and epithelial integrity. Involved in the regulation of mitotic spindle orientation, proliferation, differentiation and tissue organization of neuroepithelial cells. Involved in axonogenesis through RAB10 activation thereby regulating vesicular membrane trafficking toward the axonal plasma membrane. {ECO:0000269|PubMed:15735678, ECO:0000269|PubMed:16170365}.;
- Pathway
- Tight junction - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.326
- rvis_EVS
- -1.74
- rvis_percentile_EVS
- 2.43
Haploinsufficiency Scores
- pHI
- 0.184
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.817
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Llgl1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); craniofacial phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- llgl1
- Affected structure
- peridermal cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- exocytosis;Golgi to plasma membrane transport;axonogenesis;regulation of Notch signaling pathway;cortical actin cytoskeleton organization;regulation of establishment or maintenance of cell polarity;positive regulation of GTPase activity;establishment of spindle orientation;protein-containing complex assembly
- Cellular component
- Golgi cis cisterna;cytoplasm;cytoskeleton;plasma membrane;axon;cortical actin cytoskeleton;early endosome membrane;trans-Golgi network membrane
- Molecular function
- GTPase activator activity;structural molecule activity;protein binding;Rab GTPase binding;protein kinase binding